Every day counts in Alzheimer’s disease.
At @AlzDisInt#ADI2026: experts & advocates highlighted why national dementia strategies must shift earlier in the disease pathway, with more focus on early diagnosis, prevention, timely support & lived experience.
https://t.co/ONLFGFKNGu
#ArtificialIntelligence is rapidly transforming health research and healthcare.
This new report from @ERC_Research features expert insights, including contributions from Alina Solomon who showcases two IHI-funded projects: @AD_RIDDLE & @IHI_PROMINENT
➡️https://t.co/HTuQQzryMS
During #BAW2026 we spotlight Lena Sannemann, sharing how Public Involvement is shaping the development & implementation of @IHI_PROMINENT's digital platform for precision medicine, aimed at improving the diagnosis & treatment of neurodegenerative diseases.
https://t.co/HRm6hmnCoC
📣We’re pleased to see our partner Alzheimer Europe launching its new 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 webinar series!
The 1st session will focus on data sharing in dementia research. @AD_RIDDLE will be represented by Alina Solomon.
https://t.co/gK8QzBY2gX
#BrainAwarenessWeek
Registrations are open for @alzheimereurope's Research Insights webinar on data sharing in dementia research
22 April 2026
14:00-16:00
Linus Jonsson will present on how PROMINENT is integrating data to support clinical decision-making.
#BAW2026
Register https://t.co/PeffLHST9m
Could digital tools and Public Involvement improve dementia diagnosis and care? Read our interview with Aniek van Gils, Paco Escudero and Nigel Hullah on PROMINENT.
https://t.co/NV68odmlVu
#BAW2026#BrainAwarenessWeek2026
How can digital tools support clinical decisions in dementia care?
The @ihi_prominent project is developing a system using multimodal patient data to predict disease progression & outcomes.
Read the interview with Ini Umoh: https://t.co/sql2ACMoul
#BAW2026#BrainAwarenessWeek2026
#BrainAwarenessWeek
Our @ihieurope@ihi_prominent project is creating a digital platform for precision medicine to improve the diagnosis and treatment of neurodegenerative disease & co-morbidities.
https://t.co/ZAz1j70SDS
#AAICNeuro starts today! 🔬
On Thursday, Feb. 26, Dr. @M_SuarezCalvet will deliver the plenary presentation on “Global Perspectives - Biomarker Advancements in Dementia Diagnosis”. 👇
Patient-centered diagnostic summary reports for dementia care, developed in our @ihieurope funded project have been published on the Innovation Radar's public website:
https://t.co/TjU9yQeMbn
@alzheimereurope has been recognised as 'key innovator' with this ♀️-led innovation
Have a read of the latest @ihieurope funded @IHI_PROMINENT newsletter issue, covering project updates, a study finding that common health conditions can influence Alzheimer’s disease blood tests and our consortium meeting.
https://t.co/t8Qx7Sk8jP
Our Innovative Health Initiative (IHI) funded @IHI_PROMINENT project kicks off 2026 with continued progress across all teams. Find out about our latest activities:
https://t.co/aJlvYy7MiM
.@IHI_Access_AD builds on other IHI initiatives including @IHI_PROMINENT, @predictom , @AD_RIDDLE and @imi_epnd, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.
👋Hello from ACCESS-AD!
We’re delighted to launch ACCESS-AD, a new IHI project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across 🇪🇺
Read our press release: https://t.co/NePftsePeh
👋Hello from ACCESS-AD!
We’re delighted to launch ACCESS-AD, a new IHI project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across 🇪🇺
Read our press release: https://t.co/NePftsePeh
New research focuses on enhancing the diagnostic precision in Alzheimer's disease and the impact of comorbidities on blood-based biomarkers
https://t.co/hkJKjtwph7
🚨NEW paper published in Alzheimer's & Dementia investigating the diagnostic accuracy and clinical utility of key Alzheiemer's disease-related plasma biomarkers.
Congratulations to all authors👏
@IHIEurope@goteborgsuni@IHI_PROMINENT
Check it out⤵️
https://t.co/SfE6NUcfjQ
Partners of the @IHI_PROMINENT project met in Stockholm and online for the third consortium meeting to review Mid-Term Review feedback, advance the cNeuro-based digital platform and plan next steps
https://t.co/jU0G3eI1uN